The number of people who have recuperated from the disease surged to 4,11,80,751.
India's COVID-19 tally had crossed the 20-lakh mark on August 7, 30 lakh on August 23 and 40 lakh on September 5. It went past 50 lakh on September 16, 60 lakh on September 28, 70 lakh on October 11 and crossed 80 lakh on October 29.
The daily positivity rate was recorded at 4.54 per cent while the weekly positivity rate was recorded at 7.57 per cent.
There are now 1,348 testing labs in the country comprising 914 in the public sector and 434 private labs.
According to government sources, the matter was discussed by the national expert group on vaccine administration for COVID-19 in its last meeting held on August 22.
The death toll climbed to 5,02,874 with 895 more fatalities, the data updated at 8 am stated.
Registering a steady increase for the 18th day in row, the active cases have increased to 4,86,310 comprising 4.06 per cent of the total infections, while the recovery rate has further dropped to 94.58 per cent, the data stated.
There are 6,68,154 active cases of COVID-19 in the country as on date which comprise 8.50 per cent of the total caseload, the data stated.
ICMR Director General said some studies have suggested that antibodies last for three months while some others said they may last in the body for up to five months also.
There are 7,72,055 active cases of coronavirus infection in the country which comprises 10.23 per cent of the total caseload, the data stated.
AI tech that study CT scans and X-Rays are being deployed as part of global efforts to tackle the coronavirus pandemic, according to LPU researchers. The system may enable doctors and medical staff even in remotest villages of the country to get quick results on the COVID-19 status of a patient.
The association's reaction came after Union Health Minister Harsh Vardhan on Sunday said that the country is "in the end game of the COVID-19 pandemic" and Delhi Health Minister Satyendar Jain said the coronavirus is nearing an "endemic" phase in the national capital.
A plea has been filed in the Supreme Court challenging the rules issued by the Union health ministry which prohibit donor gametes to couples desirous of having children through surrogacy on the ground that it frustrates the provisions of the Surrogacy (Regulation) Act, 2021, which gives the right of parenthood to infertile couples.
The death toll has climbed to 4,89,848 with 439 fresh fatalities, the data updated at 8 am stated.
There has been a 4.36 per cent increase in Omicron cases since Thursday, the ministry said.
India's COVID-19 tally rose to 1,11,92,088 with over 18,000 fresh cases being reported in a span of 24 hours in the country after 36 days, while active cases registered an increase for the fourth consecutive day on Saturday and were recorded at 1,80,304, according to the Union health ministry.
The number of people who have recuperated from the disease has gone up to 4,24,85,534.
The figures updated at 8 am showed that while 95,880 people recovered from the virus in a span of 24 hours, 93,337 new infections were recorded during the period.
The tally of active cases now comprises 0.05 per cent of the total infections.
According to sources, so far only one traveller from Canada having symptoms of monkeypox infection had been isolated.
When several opposition MPs expressed their desire to ask questions about the Centre's vaccination policy such as increasing the gap between two doses, the BJP MPs strongly opposed it and few of them even demanded postponement of the meeting and walked out, the sources said.
India logged 34,973 new coronavirus infections taking the total tally of COVID-19 cases to 3,31,74,954, while the active cases declined to 3,90,646, according to the Union health ministry data updated on Friday.
'The ICMR and Biological E Limited, Hyderabad, have developed highly purified antisera (raised in animals) for prophylaxis and treatment of COVID-19,' the apex health research body said on Thursday. The 'antisera' is yet to undergo human clinical trials to establish its safety and efficacy and Drugs Controller General of India would be approached soon in this regard, Dr Samiran Panda, the head of epidemiology and communicable diseases at the ICMR said.
All COVID vaccines do not prevent infection and are primarily disease-modifying, said Dr Balram Bhargava, director general, Indian Council of Medical Research on Thursday.
The Union health ministry on Wednesday dismissed media reports claiming there was dissent from technical experts about increasing the gap between two Covishield doses and said the decision was based on scientific reason about the behaviour of adenovector vaccines.
According to Dr V N Katoch, Director Indian Council of Medical Research (ICMR) several influenza viruses keep on circulating among human, birds and animals like pigs and keep on recombining and reasserting with each others. These changes cause genetic variations among these viruses and new viruses emerge in this process.
SP leader Akhilesh Yadav reacted quickly to the allegation, tweeting that the red caps are a 'red alert' for the Bharatiya Janata Party itself as they will oust that party from power.
The active cases comprise 1.03 per cent of the total infections while the national COVID-19 recovery rate was recorded at 97.63 per cent, the ministry said.
India is the third worst-hit nation by the pandemic after the US and Brazil in terms of cases and deaths.
India logged 36,571 new coronavirus infections, taking the total tally of Covid-19 cases to 3,23,58,829, while the national recovery rate improved to 97.54 per cent, the highest since March 2020, according to the Union health ministry data updated on Friday.
India saw a single-day rise of 38,667 coronavirus infections, taking the total tally of cases to 3,21,56,493, while the death toll rose to 4,30,732 with 478 fresh fatalities, according to the Union health ministry data updated Saturday.
The minister said he was not supposed to say anything officially as he was still in touch with the union health ministry and the ICMR officials.
A total of 1,59,632 new coronavirus infections were reported in a day, the highest in 224 days.
The number of people who have recuperated from the disease surged to 3,10, 99,771, while the case fatality rate stands at 1.34 per cent.
Covaxin is being developed by Bharat Biotech jointly with the Indian Council of Medical Research (ICMR)- National Institute of Virology (NIV). The Phase III human clinical trials of Covaxin began mid-November, targeted to be done in 26,000 volunteers and it is the country's first and only Phase III efficacy study for a COVID-19 vaccine, a press release from the vaccine maker said on Saturday night.
Three COVID-19 vaccine candidates, including two indigenous ones, are in different phases of development in India.
India logged 44,877 infections, while the death toll climbed to 5,08,665 with 684 fresh fatalities, the data updated at 8 am stated.
Minister for Health and Family Welfare Anbumani Ramadoss is on an official visit to China,
The interim findings of the trial in which the four drugs were tested in 405 hospitals across 30 countries, covering 11,266 adults, were released on 'medRxiv', a preprint server, on Thursday. The findings are under review for publication in a medical journal.
© 2026 Rediff.com - Advertise with us - Disclaimer - Privacy Policy - Sitemap - Feedback - About us - Terms of use - Grievances